KEY FEATURES
Full Name | Oxidized Low Density Lipoprotein |
---|---|
Synonym | OL |
Assay Type | Sandwich |
Reactivity | Human |
Range | 31.25-2000pg/ml |
Sensitivity | 18.75pg/ml |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human OxLDL in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human OxLDL. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human OxLDL and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human OxLDL, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human OxLDL. You can calculate the concentration of Human OxLDL in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human OxLDL ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/ml) | 109.59 | 226.85 | 700.27 | 117.83 | 230.05 | 701.11 |
Standard deviation | 6.68 | 9.82 | 33.33 | 8.22 | 12.12 | 24.12 |
CV(%) | 6.1 | 4.33 | 4.76 | 6.98 | 5.27 | 3.44 |
RECOVERY
The recovery of Human OxLDL spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 96-111 | 102 |
EDTA plasma (n=8) | 87-99 | 92 |
Cell culture media (n=8) | 90-104 | 97 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human OxLDL in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with P21 ELISA Kits
BRAF ELISA Kit | publications with P21 and BRAF |
PIK3CA ELISA Kit | publications with P21 and PIK3CA |
EGFR ELISA Kit | publications with P21 and EGFR |
SRC ELISA Kit | publications with P21 and SRC |
SOS1 ELISA Kit | publications with P21 and SOS1 |
RAF1 ELISA Kit | publications with P21 and RAF1 |
RALGDS ELISA Kit | publications with P21 and RALGDS |
RIN1 ELISA Kit | publications with P21 and RIN1 |
RASA1 ELISA Kit | publications with P21 and RASA1 |
Pathways associated with P21 ELISA Kit
AGE-RAGE Signaling Pathway In Diabetic Complications | AGE-RAGE Signaling Pathway In Diabetic Complications |
ARMS-mediated Activation Pathway | ARMS-mediated Activation Pathway |
Activation Of NMDA Receptor Upon Glutamate Binding And Postsynaptic Events Pathway | Activation Of NMDA Receptor Upon Glutamate Binding And Postsynaptic Events Pathway |
Activation Of RAS In B Cells Pathway | Activation Of RAS In B Cells Pathway |
Acute Myeloid Leukemia Pathway | Acute Myeloid Leukemia Pathway |
Adaptive Immune System Pathway | Adaptive Immune System Pathway |
Alcoholism Pathway | Alcoholism Pathway |
Diseases associated with P21 ELISA Kit
Carcinoma | publications with P21 and Carcinoma |
Neoplastic Processes | publications with P21 and Neoplastic Processes |
Cell Transformation, Neoplastic | publications with P21 and Cell Transformation, Neoplastic |
Breast Neoplasms | publications with P21 and Breast Neoplasms |
Carcinoma, Squamous Cell | publications with P21 and Carcinoma, Squamous Cell |
Lung Neoplasms | publications with P21 and Lung Neoplasms |
Skin Neoplasms | publications with P21 and Skin Neoplasms |
Costello Syndrome | publications with P21 and Costello Syndrome |
Disease Progression | publications with P21 and Disease Progression |
Neoplasms, Experimental | publications with P21 and Neoplasms, Experimental |
Organs/Tissues associated with P21 ELISA Kit
Blood | publications with P21 and Blood |
Skin | publications with P21 and Skin |
Lung | publications with P21 and Lung |
Brain | publications with P21 and Brain |
Liver | publications with P21 and Liver |
Vascular | publications with P21 and Vascular |
Muscle | publications with P21 and Muscle |
Bone | publications with P21 and Bone |
Heart | publications with P21 and Heart |
Stomach | publications with P21 and Stomach |